4 weeks Royalty Pharma (NASDAQ:RPRX) Cut to Hold at StockNews.comMarketBeat
StockNews.com downgraded shares of Royalty Pharma from a “buy” rating to a “hold” rating in a research report on Monday.
XStockNews.com downgraded shares of Royalty Pharma from a “buy” rating to a “hold” rating in a research report on Monday.
X